Pol Siso
Lleida, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
ARID1A deficiency reprograms the tumor secretome, enhancing microenvironmental remodeling and metastatic dissemination in endometrial carcinoma.
Journal: Cell death & disease
Published: July 07, 2025
High Copy Number Variations Correlate with a Pro-Tumoral Microenvironment and Worse Prognosis in Acral Lentiginous Melanoma.
Journal: International journal of molecular sciences
Published: March 19, 2025
M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors.
Journal: British journal of cancer
Published: November 23, 2021
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.
Journal: Molecular oncology
Published: September 23, 2021
BRAFV600E Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics.
Journal: Cancers
Published: August 31, 2021
T-Type Calcium Channels: A Potential Novel Target in Melanoma.
Journal: Cancers
Published: January 16, 2020
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma.
Journal: The Journal of investigative dermatology
Published: June 07, 2019
In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis.
Journal: Frontiers in cell and developmental biology
Published: January 28, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026